Press Releases News / Events Overview Press Releases In The News IR Calendar Email Alerts Year All Years 2021 2020 2019 Category All Releases Financial Releases NeuBase Therapeutics Reports Financial Results for Fiscal Year 2019 Jan 09, 2020 4:05pm EST NeuBase Therapeutics Wins The Scientist’s Top 10 Innovations of 2019 Award for its Janus Base Technology Dec 02, 2019 8:00am EST NeuBase Therapeutics to Present at Upcoming Investor Conferences in December Nov 25, 2019 8:00am EST NeuBase Therapeutics to Present at the Stifel 2019 Healthcare Conference Nov 12, 2019 9:16am EST NeuBase Therapeutics Announces Issuance of Foundational Patent Covering the Key Building Blocks of PATrOL™ Enabled Therapies Oct 17, 2019 8:00am EDT NeuBase Therapeutics Announces Appointment of Cancer Biologist and RNA Therapeutics Specialist Steven Dowdy, Ph.D., to Scientific Advisory Board Oct 11, 2019 8:00am EDT NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference Sep 26, 2019 9:08am EDT NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th Sep 09, 2019 8:39am EDT NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019 Aug 14, 2019 4:05pm EDT NeuBase Therapeutics to Ring the NASDAQ Closing Bell Today Aug 07, 2019 8:00am EDT Prev 1 2 3 4 5 Next
NeuBase Therapeutics Wins The Scientist’s Top 10 Innovations of 2019 Award for its Janus Base Technology Dec 02, 2019 8:00am EST
NeuBase Therapeutics Announces Issuance of Foundational Patent Covering the Key Building Blocks of PATrOL™ Enabled Therapies Oct 17, 2019 8:00am EDT
NeuBase Therapeutics Announces Appointment of Cancer Biologist and RNA Therapeutics Specialist Steven Dowdy, Ph.D., to Scientific Advisory Board Oct 11, 2019 8:00am EDT
NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference Sep 26, 2019 9:08am EDT
NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th Sep 09, 2019 8:39am EDT
NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019 Aug 14, 2019 4:05pm EDT
